Curaleaf offer undervalues Aurora medical business, CEO says
Curaleaf’s offer is seen as undervaluing Aurora’s medical cannabis business, according to the CEO.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
Curaleaf’s offer is seen as undervaluing Aurora’s medical cannabis business, according to the CEO.